All terms in HP
| Label | Id | Description |
|---|---|---|
| erythroid progenitor cell | CL_0000038 | [A progenitor cell committed to the erythroid lineage.] |
| lymphocyte | CL_0000542 | [A lymphocyte is a leukocyte commonly found in the blood and lymph that has the characteristics of a large nucleus, a neutral staining cytoplasm, and prominent heterochromatin.] |
| Decreased serum complement factor B | HP_0005416 | [A reduced level of the complement component factor B in circulation.] |
| Increased alpha-globulin | HP_0005413 | [An abnormally increased level of circulationg alpha-globulin. Alpha globulins are a group of serum proteins defined by their mobility on serum electrophoresis. The alpha1-protein fraction is comprised of alpha1-antitrypsin, thyroid-binding globulin, and transcortin. Ceruloplasmin, alpha2-macroglobulin, and haptoglobin contribute to the alpha2-protein band. The alpha2 component is increased as an acute-phase reactant.] |
| Chronic intestinal candidiasis | HP_0005411 | [Persistent overgrowth of Candida albicans in the gastrointestinal tract.] |
| hematopoietic oligopotent progenitor cell | CL_0002032 | [A hematopoietic oligopotent progenitor cell that has the ability to differentiate into limited cell types but lacks lineage cell markers and self renewal capabilities. Cell lacks hematopoeitic lineage markers.] |
| hematopoietic multipotent progenitor cell | CL_0000837 | [A hematopoietic multipotent progenitor cell is multipotent, but not capable of long-term self-renewal. These cells are characterized as lacking lineage cell surface markers and being CD34-positive in both mice and humans.] |
| malignant cell | CL_0001064 | [A neoplastic cell that is capable of entering a surrounding tissue] |
| neoplastic cell | CL_0001063 | [An abnormal cell exhibiting dysregulation of cell proliferation or programmed cell death and capable of forming a neoplasm, an aggregate of cells in the form of a tumor mass or an excess number of abnormal cells (liquid tumor) within an organism.] |
| abnormal cell | CL_0001061 | [A cell found in an organism or derived from an organism exhibiting a phenotype that deviates from the expected phenotype of any native cell type of that organism. Abnormal cells are typically found in disease states or disease models.] |
| cell | CL_0000000 | [A material entity of anatomical origin (part of or deriving from an organism) that has as its parts a maximally connected cell compartment surrounded by a plasma membrane.] |
| vascular endothelial growth factor receptor 2 (mouse) | PR_P35918 | [A vascular endothelial growth factor receptor 2 that is encoded in the genome of mouse.] |
| vascular endothelial growth factor receptor 2 | PR_000002112 | [A vascular endothelial growth factor receptor that is a translation product of the human KDR gene or a 1:1 ortholog thereof.] |
| Decreased T cell activation | HP_0005419 | [Decreased or impaired activation of T cells in response to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific.] |
| Abnormal T cell activation | HP_0410035 | [Any abnormality in the activation of T cells, i.e. the change in morphology and behavior of a mature or immature T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific.] |
| Decreased circulating androgen level | HP_0030349 | [A reduction in the blood concentration of an androgen, that is, of a steroid hormone that controls development and maintenance of masculine characteristics. The androgens include testosterone and Dehydroepiandrosterone.] |
| regulation of eating behavior | NBO_0000063 | |
| regulation of feeding behavior | NBO_0002436 | |
| Depletion of components of the alternative complement pathway | HP_0005389 | [An abnormal reduction in the components of the alternative complement pathway, such as the C3 protein or its cleavage products.] |
| Abnormal circulating luteinizing hormone level | HP_0030345 | [An anomaly of the circulating level of luteinizing hormone (LH).] |